JUNE 8, 2026 Incyte to Acquire Vega Therapeutics Forward looking statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding the anticipated benefits of the Vega Therapeutics acquisition; expectations regarding VGA039's strategic fit within Incyte's hematology portfolio, its favorable risk-reward profile, potential to transform the current treatment paradigm, expe ...